Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FGFR3 | P22607 | 11/20 | 0.46 |
| ▸ | KDR | P35968 | 8/20 | 0.46 |
| ▸ | FGFR2 | P21802 | 11/20 | 0.41 |
| ▸ | FGFR1 | P11362 | 10/20 | 0.41 |
| ▸ | FGFR4 | P22455 | 8/20 | 0.41 |
| ▸ | EGFR | P00533 | 3/20 | 0.40 |
| ▸ | BTK | Q06187 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31655645 | 1.00 | FGFR3 (0.46) | FGFR3KDRFGFR2FGFR1FGFR4 | |
| SCHEMBL31655616 | 0.89 | FGFR3 (0.50) | FGFR3KDRFGFR2FGFR1FGFR4 | |
| SCHEMBL22149692 | 0.89 | FGFR3 (0.50) | FGFR3KDRFGFR2FGFR1FGFR4 | |
| SCHEMBL22149690 | 0.87 | FGFR3 (0.44) | FGFR3KDRFGFR2FGFR1FGFR4 | |
| SCHEMBL31655634 | 0.87 | FGFR3 (0.44) | FGFR3KDRFGFR2FGFR1FGFR4 | |
| SCHEMBL31655625 | 0.85 | FGFR3 (0.52) | FGFR3KDRFGFR2FGFR1FGFR4 | |
| SCHEMBL31655649 | 0.83 | FGFR3 (0.51) | FGFR3KDRFGFR2FGFR1FGFR4 | |
| SCHEMBL22149351 | 0.78 | FGFR3 (0.49) | FGFR3KDRFGFR2FGFR1FGFR4 | |
| SCHEMBL31655614 | 0.78 | FGFR3 (0.49) | FGFR3KDRFGFR2FGFR1FGFR4 | |
| SCHEMBL22149197 | 0.78 | FGFR3 (0.39) | FGFR3KDRFGFR2FGFR1FGFR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020131674-A1 | 7-((3,5-DIMETHOXYPHENYL)AMINO)QUINOXALINE DERIVATIVES AS FGFR INHIBITORS FOR TREATING CANCER | ARRAY BIOPHARMA INC. (US) | 2020-06-25 | — | — | WO | disclosed |